World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
12686
World Ranking
3246
National Ranking
144

Maxime Breban publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Maxime Breban sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 235 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Maxime Breban D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Maxime Breban sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Maxime Breban is affiliated with the University of Paris-Saclay in France. Their research primarily focuses on medicine, with significant contributions to rheumatology, immunology, hematology, surgery, and obstetrics and gynecology. The subfield of rheumatology stands out as the area with the highest number of publications.

The main topics covered in Maxime Breban's research include:

  • Spondyloarthritis Studies and Treatments
  • Psoriasis: Treatment and Pathogenesis
  • Autoimmune and Inflammatory Disorders Research
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Bone and Joint Diseases

Breban's body of work includes numerous scientific papers published in various venues. Frequent publication journals include:

  • Revue du Rhumatisme
  • Annals of the Rheumatic Diseases
  • Joint Bone Spine
  • Lara D. Veeken
  • Arthritis Research & Therapy

Among the recent notable papers are:

  • "Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis," 2021, Annals of the Rheumatic Diseases
  • "Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility Loci," 2020, Investigative Ophthalmology & Visual Science
  • "EULAR study group on 'MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders," 2023, Annals of the Rheumatic Diseases
  • "Both Disease Activity and HLA-B27 Status Are Associated With Gut Microbiome Dysbiosis in Spondyloarthritis Patients," 2022, Arthritis & Rheumatology
  • "COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence," 2020, Joint Bone Spine

Maxime Breban frequently collaborates with several researchers. The most common co-authors include:

  • Félicie Costantino
  • Maria Antonietta D'Agostino
  • Simon Glatigny
  • Daniel Wendling
  • Bilade Cherqaoui

The breadth and scope of Maxime Breban's work covers both clinical research and mechanistic insights into autoimmune and inflammatory diseases, contributing significantly to the understanding of spondyloarthritis and related conditions.

Best Publications

  • Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry

    Florence Tubach;Dominique Salmon;Philippe Ravaud;Yannick Allanore

  • Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.

    A Cortes;J Hadler;J P Pointon

  • Faecal microbiota study reveals specific dysbiosis in spondyloarthritis

    Maxime Breban;Julien Tap;Ariane Leboime;Roula Said-Nahal

  • Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1.

    Adrian Cortes;Sara L. Pulit;Paul J. Leo;Jenny J. Pointon

  • The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients.

    Maxime Dougados;Maria-Antonietta d’Agostino;Joëlle Benessiano;Francis Berenbaum

  • ImmunoChip Study Implicates Antigen Presentation to T Cells in Narcolepsy

    Juliette Faraco;Ling Lin;Birgitte Rahbek Kornum;Birgitte Rahbek Kornum;Eimear E. Kenny

  • Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.

    Joel D Taurog;Shanna D. Maika;William A. Simmons;Maxime Breban

  • Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry

    Jacques-Eric Gottenberg;Gael Cinquetti;Claire Larroche;Bernard Combe

  • Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography

    X Baraliakos;F Heldmann;J Callhoff;J Listing

  • T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats.

    M Breban;J L Fernández-Sueiro;J A Richardson;R R Hadavand

  • Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial.

    Jacques-Eric Gottenberg;Olivier Brocq;Aleth Perdriger;Slim Lassoued

  • Efficacy of infliximab in refractory ankylosing spondylitis: results of a six‐month open‐label study

    M. Breban;E. Vignon;P. Claudepierre;V. Devauchelle

  • Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment.

    Maxime Breban;Robert E. Hammer;James A. Richardson;Joel D. Taurog

  • The familial form of spondylarthropathy: A clinical study of 115 multiplex families

    Roula Said‐Nahal;Corinne Miceli‐Richard;Jean‐Marie Berthelot;Agnès Duché

  • Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists

    Haïfa Hamdi;Xavier Mariette;Véronique Godot;Karin Weldingh

  • HLA-B27 Heavy Chain Homodimers Are Expressed in HLA-B27 Transgenic Rodent Models of Spondyloarthritis and Are Ligands for Paired Ig-Like Receptors

    Simon Kollnberger;Lucy A. Bird;Matthew Roddis;Cecile Hacquard-Bouder

  • Prevalence of ultrasound synovial inflammatory findings in healthy subjects

    Ilaria Padovano;Félicie Costantino;Maxime Breban;Maria Antonietta D'Agostino

  • Proinflammatory Th17 cells are expanded and induced by dendritic cells in spondylarthritis-prone HLA-B27-transgenic rats.

    Simon Glatigny;Ingrid Fert;Marie A. Blaton;Rik J. Lories

  • Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: The DESIR cohort.

    Maxime Dougados;Adrien Etcheto;Anna Molto;Sandrine Alonso

  • Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy

    Jérémie Sellam;Haifa Hamdi;Carine Roy;Gabriel Baron

  • Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

    A. Cortes;J. Hadler;J.P. Pointon;P.C. Robinson

Frequent Co-Authors

Gilles Chiocchia
Gilles Chiocchia Grenoble Alpes University
Maxime Dougados
Maxime Dougados Hôpital Cochin
Matthew A. Brown
Matthew A. Brown Guy's and St Thomas' NHS Foundation Trust
Alain Saraux
Alain Saraux University of Western Brittany
Dirk Elewaut
Dirk Elewaut Ghent University
John D. Reveille
John D. Reveille The University of Texas Health Science Center at Houston
Jaakko Tuomilehto
Jaakko Tuomilehto University of Helsinki
Bruno Fautrel
Bruno Fautrel Université Paris Cité
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Corinne Miceli-Richard
Corinne Miceli-Richard Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related healthcare degrees can open diverse career opportunities. Many professionals choose to advance their expertise through specialized nursing programs that align with their interests in patient care and biomedical sciences.

One popular path is enrolling in the cheapest pmhnp programs, which provide a cost-effective option for students pursuing psychiatric nursing while building a strong foundation in biological and behavioral health.

Graduates holding a Doctorate in Nursing can expect competitive compensation, as highlighted by the doctorate in nursing salary data, which varies by state but typically reflects the advanced skills and knowledge gained through rigorous education.

If you are a Family Nurse Practitioner looking to specialize further, transitioning through resources like fnp to acnp programs can provide clear guidance on shifting into acute care settings, an area closely related to immunology and critical patient care.

Additionally, accelerated study options, such as those featured in the accelerated nurse practitioner program listings, help motivated students rapidly gain credentials and enter the workforce, merging flexibility with speed in career advancement.

Best Scientists Citing Maxime Breban

Trending Scientists

Recently Published Articles